High-Affinity N-(2-Hydroxypropyl)methacrylamide Copolymers with Tailored N-Acetyllactosamine Presentation Discriminate between Galectins
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Acrylamides chemistry MeSH
- Amino Sugars chemistry MeSH
- Bacillus enzymology MeSH
- beta-Galactosidase metabolism MeSH
- Disaccharides chemical synthesis MeSH
- Enzyme-Linked Immunosorbent Assay MeSH
- Epitopes MeSH
- Galectin 1 analysis metabolism MeSH
- Galectins analysis metabolism MeSH
- Catalysis MeSH
- Blood Proteins analysis metabolism MeSH
- Magnetic Resonance Spectroscopy MeSH
- Polymerization MeSH
- Polymers chemistry metabolism pharmacology MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Acrylamides MeSH
- Amino Sugars MeSH
- beta-Galactosidase MeSH
- Disaccharides MeSH
- Epitopes MeSH
- Galectin 1 MeSH
- Galectins MeSH
- Blood Proteins MeSH
- LGALS1 protein, human MeSH Browser
- LGALS3 protein, human MeSH Browser
- N-(2-hydroxypropyl)methacrylamide MeSH Browser
- N-acetyllactosamine MeSH Browser
- Polymers MeSH
N-Acetyllactosamine (LacNAc; Galβ4GlcNAc) is a typical disaccharide ligand of galectins. The most abundant members of these human lectins, galectin-1 (Gal-1) and galectin-3 (Gal-3), participate in a number of pathologies including cancerogenesis and metastatic formation. In this study, we synthesized a series of fifteen N-(2-hydroxypropyl)methacrylamide (HPMA)-based glycopolymers with varying LacNAc amounts and presentations and evaluated the impact of their architecture on the binding affinity to Gal-1 and Gal-3. The controlled radical reversible addition-fragmentation chain transfer copolymerization technique afforded linear polymer precursors with comparable molecular weight (Mn ≈ 22,000 g mol-1) and narrow dispersity (D̵ ≈ 1.1). The precursors were conjugated with the functionalized LacNAc disaccharide (4-22 mol % content in glycopolymer) prepared by enzymatic synthesis under catalysis by β-galactosidase from Bacillus circulans. The structure-affinity relationship study based on the enzyme-linked immunosorbent assay revealed that the type of LacNAc presentation, individual or clustered on bi- or trivalent linkers, brings a clear discrimination (almost 300-fold) between Gal-1 and Gal-3, reaching avidity to Gal-1 in the nanomolar range. Whereas Gal-1 strongly preferred a dense presentation of individually distributed LacNAc epitopes, Gal-3 preferred a clustered LacNAc presentation. Such a strong galectin preference based just on the structure of a multivalent glycopolymer type is exceptional. The prepared nontoxic, nonimmunogenic, and biocompatible glycopolymers are prospective for therapeutic applications requiring selectivity for one particular galectin.
References provided by Crossref.org
Cross-Linking Effects Dictate the Preference of Galectins to Bind LacNAc-Decorated HPMA Copolymers